-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse London Stock Exchange-
AltimmuneBörse Börse FrankfurtSymbol 3G0
-
AltimmuneBörse Börse BerlinSymbol 3G0
-
AltimmuneBörse Börse MünchenSymbol 3G0
-
ALTIMMUNE INCBörse Börse DüsseldorfSymbol 3G0
-
ALTIMMUNE INCBörse Börse StuttgartSymbol 3G0
-
ALTIMMUNE INCBörse Quotrix System der Börse DüsseldorfSymbol 3G0
-
ALTIMMUNE INCBörse Tradegate System der Deutsche Börse AG (60%)Symbol 3G0
-
ALTIMMUNE INCBörse Gettex System der Börse MünchenSymbol 3G0
-
ISIN US02155H2004 WKN: A2N5Z6Symbol ALT
-
AltimmuneBörse NasdaqISIN US02155H2004
-
AltimmuneBörse London Stock Exchange
-
AltimmuneBörse Bolsa Mexicana de Valore Mexiko-Stadt
-
Altimmune, Inc.Börse Bolsa Mexicana de Valore Mexiko-Stadt
-
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
825.315.200 oder 20.000.000
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
25 oder 52 Mitarbeiter
Ein ETF investiert in Altimmune, Inc
Dir gefallen die Informationen zu Altimmune?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Altimmune?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Dir gefallen die Informationen zu Altimmune?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Altimmune?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
28 News & Informationen zur Altimmune Aktie
Are Options Traders Betting on a Big Move in Altimmune (ALT) Stock?
Investors need to pay close attention to Altimmune (ALT) stock based on the movements in the options market lately.
Global Biodefense Market (2021 to 2025) – Featuring ANP Technologies, Bavarian Nordic and GlaxoSmithKline Among Others
/PRNewswire/ — The
Tang Capital Management Llc Buys Heron Therapeutics Inc, Vincerx Pharma Inc, Altimmune Inc, Sells Relmada Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
Acuta Capital Partners, Llc Buys BCLS Acquisition Corp, Vincerx Pharma Inc, Cyteir Therapeutics Inc, Sells 89bio Inc, Curis Inc, Trillium Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
Bharat Biotech's BBV154 leads global race for intranasal COVID-19 vaccine
At present out of the 110 vaccines under clinical development globally, only eight are intranasal vaccines and three are oral vaccines
Altimmune, Inc. (ALT) CEO Vipin Garg on Q2 2021 Results – Earnings Call Transcript
Altimmune, Inc. (NASDAQ:ALT) Q2 2021 Results Conference Call August 11, 2021, 08:30 AM ET Company Participants Vipin Garg – President and Chief Executive Officer Will Brown – Chief…
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnin…
Global Drug Delivery Systems (DDS) Markets 2021-2027 – Increasing R&D Expenditures Of Innovator Companies And The Trend Of Patent Portfolio Expansion
DUBLIN, July 29, 2021 /PRNewswire/ — The
Altimmune: NASH And Obesity At The End Of The COVID Tunnel (NASDAQ:ALT)
Altimmune (ALT) stock sold off after the company announced its plan to scrap its COVID19 vaccine programs, and ALT is currently trading at an enterprise value of around US$120M.
Jim Cramer’s Game Plan for This Week and the Start of Earnings Season – 24
24/7 Wall St. takes a look at famed market personality Jim Cramer’s latest buy and sell recommendations and overall analysis.
Cramer Gives His Opinion On AT&T, Cemex And More
On CNBC's
Biodefense Market Growth Analysis in Biotechnology Industry | Technavio
/PRNewswire/ — Set to grow by USD 5.41 billion during 2021-2025, Technavio's latest market research report estimates the biodefense market to register a CAGR…
Biodefense Market Growth Analysis in Biotechnology Industry | Technavio
NEW YORK, July 7, 2021 /PRNewswire/ — Set to grow by USD 5.41 billion during 2021-2025, Technavio's latest market research report estimates the b…
The Week Ahead In Biotech: Focus On Chemocentryx FDA Decision, Conference Presentations In A Light Week
Biotech stocks advanced for a second week in running, with stocks reacting to pending releases for the second quarter and the first-half of the ye…
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.61% By Investing.com
U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.61%
Why Altimmune Is Crashing Today
The company halts development on both a COVID-19 vaccine and a drug targeting the disease.
Mid-Day Market Update: Barnes & Noble Education Drops Following Q4 Results; Aerovate Therapeutics Shares Surge
Midway through trading Wednesday, the Dow traded up 0.42% to 34,437.23 while the NASDAQ fell 0.14% to 14,508.18. The S&P also rose, gaining 0.06% to …
Why Novavax Stock Is Rising Today
It could be related to a potential rival's bad news.
Shaky Futures Close Out Second Best First Half Since 1998
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
Altimmune Tanks 35% After It Discontinues Covid-19 Vaccine Development
Shares of Altimmune Inc. (ALT) plunged 35% in extended session on Tuesday after the clinical-stage biopharmaceutical company said that its stopping development of its investigational Covid-19 vaccine AdCOVID.
Altimmune Announces Update On AdCOVID™ Phase 1 Clinical Trial
AdCOVID was well tolerated but did not stimulate an adequate immune response in healthy volunteers
Altimmune will discontinue further development of
Hedge Funds Are Buying Mercantile Bank Corp. (MBWM)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings…
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (…
Should I Avoid First Community Bancshares Inc (FCBC)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
Could AstraZeneca's Nasal COVID Vaccine Development Zap Altimmune's Prospects?
The short answer: It depends.
Could This Under-the-Radar COVID Stock Be a Millionaire-Maker?
This biotech just might have what it takes.
3 coronavirus stocks poised to soar in 2021
They’re risky but could deliver huge returns in the new year.
3 Coronavirus Stocks Poised to Soar in 2021
They’re risky but could deliver huge returns in the new year.